MENU
+Compare
AMPH
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$29.42
Change
+$0.23 (+0.79%)
Capitalization
1.37B

AMPH Amphastar Pharmaceuticals Forecast, Technical & Fundamental Analysis

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products... Show more

AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AMPH with price predictions
Sep 04, 2025

AMPH in upward trend: 10-day moving average moved above 50-day moving average on August 13, 2025

The 10-day moving average for AMPH crossed bullishly above the 50-day moving average on August 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

AMPH moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMPH advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 224 cases where AMPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMPH moved out of overbought territory on September 03, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where AMPH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AMPH as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AMPH turned negative on September 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMPH broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.806) is normal, around the industry mean (19.044). P/E Ratio (11.019) is within average values for comparable stocks, (73.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.885). AMPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (2.048) is also within normal values, averaging (42.427).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

View a ticker or compare two or three
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMPH is expected to report earnings to 84 cents per share on November 10

Amphastar Pharmaceuticals AMPH Stock Earnings Reports
Q3'25
Est.
$0.85
Q2'25
Beat
by $0.11
Q1'25
Beat
by $0.05
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.04
The last earnings report on August 07 showed earnings per share of 85 cents, beating the estimate of 74 cents. With 414.94K shares outstanding, the current market capitalization sits at 1.37B.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary injectable and inhalation products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11570 6th Street
Phone
+1 909 980-9484
Employees
1761
Web
https://www.amphastar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
STPCX12.830.06
+0.47%
Saratoga Technology & Comm C
MWEHX46.87N/A
N/A
MFS Global Equity R3
RTLAX91.50N/A
N/A
Russell Inv Tax-Managed US Large Cap A
MIEFX15.32N/A
N/A
Matthews Emerging Markets Equity Ins
CRTSX12.36N/A
N/A
Catholic Rsp Invst Mlt-Styl US Eq Ins

AMPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.79%
AMRX - AMPH
34%
Loosely correlated
+0.73%
ZTS - AMPH
32%
Poorly correlated
+0.08%
HROW - AMPH
29%
Poorly correlated
+2.18%
VTRS - AMPH
28%
Poorly correlated
+1.65%
ANIP - AMPH
28%
Poorly correlated
-0.68%
More

Groups containing AMPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.79%
Pharmaceuticals: Generic
industry (223 stocks)
14%
Poorly correlated
+2.48%